
Human Insulatard 40IU/ml Suspension for Injection
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Insulin Isophane (40IU)
Overview Human Insulatard 40IU/ml Suspension for Injection
Insulatard 40 IU/mL injectable suspension manages blood glucose in adults and children with type 1 and 2 diabetes. This intermediate-acting insulin lowers blood sugar, mitigating diabetes complications. It's frequently used alongside rapid-acting insulin or oral antidiabetics, administered subcutaneously as instructed by your healthcare provider. Discontinuation requires medical guidance. Effective diabetes management necessitates adherence to this medication, combined with a healthy diet, regular exercise, and weight management as recommended. Regular blood glucose monitoring, recording, and sharing with your doctor are crucial for dose optimization. Hypoglycemia (low blood sugar) is the most prevalent side effect; proper dosing, consistent meals, and blood glucose monitoring are essential for prevention. Excessive alcohol intake increases hypoglycemia risk. Injection site reactions (redness, swelling) may occur; rotating injection sites prevents lipodystrophy (skin changes). Weight gain and edema (fluid retention) are potential side effects. Avoid use during hypoglycemic episodes. Prior kidney, liver, or heart conditions should be disclosed. Pregnant or breastfeeding individuals require medical consultation for potential dose adjustments.
Uses of Human Insulatard 40IU/ml Suspension for Injection
High blood sugar condition
Major Benefits of Human Insulatard 40IU/ml Suspension for Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Human Insulatard 40IU/ml Suspension for Injection:
- Hypoglycemia (low blood glucose level)
How to use Human Insulatard 40IU/ml Suspension for Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Human Insulatard 40IU/ml Suspension for Injection works:
Insulatard 40 IU/mL injectable suspension, a human insulin analog, provides intermediate-acting glycemic control. Onset of action typically occurs within one to two hours post-injection. Its mechanism mirrors endogenous insulin function, promoting glucose uptake by muscle and adipose tissue while concurrently inhibiting hepatic glucose production. This combined action results in reduced blood glucose concentrations in patients with diabetes mellitus.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Human Insulatard 40IU/ml injectable suspension is contraindicated due to safety concerns.
PregnancySAFE IF PRESCRIBED
Insulatard 40 IU/ml injectable suspension is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Insulatard 40 IU/mL injectable suspension is considered safe for breastfeeding mothers. Research in humans indicates minimal transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Individuals with impaired kidney function should use Human Insulatard 40IU/ml injectable suspension cautiously. Dosage modification of Human Insulatard 40IU/ml injectable suspension may be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage changes.
LiverCAUTION
Individuals with hepatic impairment should use Human Insulatard 40IU/ml injectable suspension cautiously, as dose modification may be necessary. Consult your physician for guidance. Routine glucose monitoring is advised to inform appropriate dosage alterations.
What if you forget to take Human Insulatard 40IU/ml Suspension for Injection :
NA
Facts to Know About Human Insulatard 40IU/ml Suspension for Injection
| Label | Value |
|---|---|
| Chemical Category | Modified insulin |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavior Class | Neutral Protamine Hagedorn (NPH) insulin |
